{"id":41539,"date":"2025-09-16T16:12:34","date_gmt":"2025-09-16T08:12:34","guid":{"rendered":"https:\/\/flcube.com\/?p=41539"},"modified":"2025-09-16T16:12:35","modified_gmt":"2025-09-16T08:12:35","slug":"shenzhen-kangtai-receives-nmpa-approval-for-sabin%e2%80%91strain-inactivated-polio-vaccine","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41539","title":{"rendered":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine"},"content":{"rendered":"\n<p><strong>Shenzhen Kangtai Biological Products Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/300601:SHE\">SHE: 300601<\/a>)<\/strong> announced today that the <strong>China National Medical Products Administration (NMPA)<\/strong> has granted approval for its <strong>Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell)<\/strong>. The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-how-the-vaccine-works\">How the Vaccine Works<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sabin\u2011Strain Basis<\/strong> \u2013 The vaccine contains inactivated Sabin strains of poliovirus types\u202fI,\u202fII, and\u202fIII.<\/li>\n\n\n\n<li><strong>Immune Response<\/strong> \u2013 Upon intramuscular injection, the immune system mounts a robust antibody response, conferring protective immunity against wild\u2011type poliovirus infection.<\/li>\n\n\n\n<li><strong>Safety Profile<\/strong> \u2013 As an inactivated formulation, it eliminates the risk of vaccine\u2011derived poliomyelitis, making it suitable for widespread immunization campaigns.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-market-landscape\">Market Landscape<\/h4>\n\n\n\n<p>Kangtai is not the only Chinese manufacturer to offer a Sabin\u2011strain inactivated vaccine. <strong>Beijing Sinovac Biotech Ltd., Beijing Institute of Biological Products Co., Ltd.,<\/strong> and the <strong>Institute of Medical Biology, Chinese Academy of Medical Sciences<\/strong> have already launched similar products. The approval positions Kangtai to compete in a growing global poliovirus vaccine market, projected to reach <strong>$1.2\u202fbillion<\/strong> by 2030.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-regulatory-and-commercial-implications\">Regulatory and Commercial Implications<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>NMPA Clearance<\/strong> \u2013 The approval enables Kangtai to market the vaccine domestically and pursue export licensing.<\/li>\n\n\n\n<li><strong>Strategic Partnerships<\/strong> \u2013 Kangtai plans to collaborate with WHO and UNICEF for global immunization initiatives, potentially securing sizable procurement contracts.<\/li>\n\n\n\n<li><strong>Pipeline Synergies<\/strong> \u2013 The company\u2019s existing expertise in Vero\u2011cell vaccine platforms will accelerate development of other inactivated viral vaccines.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-outlook\">Outlook<\/h4>\n\n\n\n<p>With the NMPA clearance secured, Shenzhen Kangtai is poised to enhance its portfolio of inactivated vaccines and support China\u2019s goal of achieving polio eradication. The company\u2019s next steps include scaling up production capacity and initiating clinical studies for broader immunization schedules.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/\u5eb7\u6cf0\u751f\u7269\uff1a\u5173\u4e8eSabin\u682a\u810a\u9ad3\u7070\u8d28\u708e\u706d\u6d3b\u75ab\u82d7\uff08Vero\u7ec6\u80de\uff09\u83b7\u5f97\u836f\u54c1\u6ce8\u518c\u8bc1\u4e66\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u5eb7\u6cf0\u751f\u7269\uff1a\u5173\u4e8eSabin\u682a\u810a\u9ad3\u7070\u8d28\u708e\u706d\u6d3b\u75ab\u82d7\uff08Vero\u7ec6\u80de\uff09\u83b7\u5f97\u836f\u54c1\u6ce8\u518c\u8bc1\u4e66\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-9a9da356-368f-444a-ba45-f0299a7b6522\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/\u5eb7\u6cf0\u751f\u7269\uff1a\u5173\u4e8eSabin\u682a\u810a\u9ad3\u7070\u8d28\u708e\u706d\u6d3b\u75ab\u82d7\uff08Vero\u7ec6\u80de\uff09\u83b7\u5f97\u836f\u54c1\u6ce8\u518c\u8bc1\u4e66\u7684\u516c\u544a.pdf\">\u5eb7\u6cf0\u751f\u7269\uff1a\u5173\u4e8eSabin\u682a\u810a\u9ad3\u7070\u8d28\u708e\u706d\u6d3b\u75ab\u82d7\uff08Vero\u7ec6\u80de\uff09\u83b7\u5f97\u836f\u54c1\u6ce8\u518c\u8bc1\u4e66\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/\u5eb7\u6cf0\u751f\u7269\uff1a\u5173\u4e8eSabin\u682a\u810a\u9ad3\u7070\u8d28\u708e\u706d\u6d3b\u75ab\u82d7\uff08Vero\u7ec6\u80de\uff09\u83b7\u5f97\u836f\u54c1\u6ce8\u518c\u8bc1\u4e66\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-9a9da356-368f-444a-ba45-f0299a7b6522\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41543,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[2361,15,1007,12],"class_list":["post-41539","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","tag-kangtai-biological-products","tag-product-approvals","tag-she-300601","tag-vaccine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical Products Administration (NMPA) has granted approval for its Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell). The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41539\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine\" \/>\n<meta property=\"og:description\" content=\"Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical Products Administration (NMPA) has granted approval for its Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell). The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41539\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T08:12:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-16T08:12:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine\",\"datePublished\":\"2025-09-16T08:12:34+00:00\",\"dateModified\":\"2025-09-16T08:12:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539\"},\"wordCount\":295,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1604.webp\",\"keywords\":[\"Kangtai Biological Products\",\"Product approvals\",\"SHE: 300601\",\"Vaccine\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41539#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41539\",\"name\":\"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1604.webp\",\"datePublished\":\"2025-09-16T08:12:34+00:00\",\"dateModified\":\"2025-09-16T08:12:35+00:00\",\"description\":\"Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical Products Administration (NMPA) has granted approval for its Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell). The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41539\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1604.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1604.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41539#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine - Insight, China&#039;s Pharmaceutical Industry","description":"Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical Products Administration (NMPA) has granted approval for its Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell). The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41539","og_locale":"en_US","og_type":"article","og_title":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine","og_description":"Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical Products Administration (NMPA) has granted approval for its Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell). The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.","og_url":"https:\/\/flcube.com\/?p=41539","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-16T08:12:34+00:00","article_modified_time":"2025-09-16T08:12:35+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41539#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41539"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine","datePublished":"2025-09-16T08:12:34+00:00","dateModified":"2025-09-16T08:12:35+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41539"},"wordCount":295,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41539#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp","keywords":["Kangtai Biological Products","Product approvals","SHE: 300601","Vaccine"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41539#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41539","url":"https:\/\/flcube.com\/?p=41539","name":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41539#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41539#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp","datePublished":"2025-09-16T08:12:34+00:00","dateModified":"2025-09-16T08:12:35+00:00","description":"Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced today that the China National Medical Products Administration (NMPA) has granted approval for its Sabin\u2011Strain Inactivated Poliomyelitis Vaccine (Vero Cell). The vaccine, developed on a Vero\u2011cell platform, is designed to prevent acute infectious disease caused by all three serotypes of the poliovirus.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41539#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41539"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41539#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp","width":1080,"height":608,"caption":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41539#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shenzhen Kangtai Receives NMPA Approval for Sabin\u2011Strain Inactivated Polio Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1604.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41539"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41539\/revisions"}],"predecessor-version":[{"id":41544,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41539\/revisions\/41544"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41543"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}